Alkermes (ALKS) Lifted to "Hold" at ValuEngine


ALKS has been the topic of a number of other research reports. Credit Suisse Group set a $66.00 price target on Alkermes and gave the stock a "buy" rating in a research report on Tuesday, November 28th.



from Biotech News